Sotera Health (SHC) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $18.07, +1.92% vs the prior close of $17.73.
- Volume 2.43M shares, 1.1x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
SHC rises 1.9% to $18.07. Closed at $18.07, +1.92% vs the prior close of $17.73. Day range $17.71–$18.19, opened at $17.88.
SHC daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — SHC rises 1.9% to $18.07
- Closed at $18.07, +1.92% vs the prior close of $17.73. Day range $17.71–$18.19, opened at $17.88.
- Volume was 2.43M shares, 1.1x its 50-day average of 2.30M.
- Price is -3.3% vs its 50-day average ($18.69) and +6.1% vs its 200-day average ($17.02).
- 52-week range $13.09–$19.85; today's close sits at 74% of that range, 9.0% below the 52-week high.
Oct 14, 2026 — SHC dips 2.6% to $17.73, a 1-month low
- Closed at $17.73, -2.64% vs the prior close of $18.21. Day range $17.62–$18.02, opened at $17.82.
- Volume was 2.28M shares, 1.0x its 50-day average of 2.30M.
- Price is -5.1% vs its 50-day average ($18.69) and +4.2% vs its 200-day average ($17.02).
- 52-week range $13.09–$19.85; today's close sits at 69% of that range, 10.7% below the 52-week high.
Oct 13, 2026 — SHC rises 0.3% to $18.21, 3 up days in a row
- Closed at $18.21, +0.33% vs the prior close of $18.15. Day range $17.92–$18.32, opened at $18.19.
- Volume was 1.65M shares, 0.7x its 50-day average of 2.30M.
- Price is -2.6% vs its 50-day average ($18.69) and +7.0% vs its 200-day average ($17.02).
- 52-week range $13.09–$19.85; today's close sits at 76% of that range, 8.3% below the 52-week high.
- That makes 3 straight gains.
Oct 12, 2026 — SHC rises 0.5% to $18.15
- Closed at $18.15, +0.50% vs the prior close of $18.06. Day range $17.94–$18.16, opened at $18.04.
- Volume was 1.56M shares, 0.7x its 50-day average of 2.30M.
- Price is -2.9% vs its 50-day average ($18.69) and +6.6% vs its 200-day average ($17.02).
- 52-week range $13.09–$19.85; today's close sits at 75% of that range, 8.6% below the 52-week high.
Oct 9, 2026 — SHC rises 1.3% to $18.06
- Closed at $18.06, +1.29% vs the prior close of $17.83. Day range $17.65–$18.24, opened at $17.83.
- Volume was 1.60M shares, 0.7x its 50-day average of 2.30M.
- Price is -3.3% vs its 50-day average ($18.68) and +6.1% vs its 200-day average ($17.02).
- 52-week range $13.09–$19.85; today's close sits at 74% of that range, 9.0% below the 52-week high.
Oct 8, 2026 — SHC dips 0.4% to $17.83, a 1-month low, 3 down days in a row
- Closed at $17.83, -0.39% vs the prior close of $17.90. Day range $17.51–$18.25, opened at $17.80.
- Volume was 2.25M shares, 1.0x its 50-day average of 2.33M.
- Price is -4.5% vs its 50-day average ($18.68) and +4.8% vs its 200-day average ($17.01).
- 52-week range $13.09–$19.85; today's close sits at 70% of that range, 10.2% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — SHC dips 1.9% to $17.90, a 1-month low
- Closed at $17.90, -1.92% vs the prior close of $18.25. Day range $17.87–$18.69, opened at $18.13.
- Volume was 1.61M shares, 0.7x its 50-day average of 2.42M.
- Price is -4.1% vs its 50-day average ($18.67) and +5.2% vs its 200-day average ($17.01).
- 52-week range $13.09–$19.85; today's close sits at 71% of that range, 9.8% below the 52-week high.
Oct 6, 2026 — SHC dips 1.6% to $18.25
- Closed at $18.25, -1.62% vs the prior close of $18.55. Day range $18.19–$18.98, opened at $18.77.
- Volume was 1.65M shares, 0.7x its 50-day average of 2.43M.
- Price is -2.2% vs its 50-day average ($18.67) and +7.3% vs its 200-day average ($17.00).
- 52-week range $13.09–$19.85; today's close sits at 76% of that range, 8.1% below the 52-week high.
Oct 5, 2026 — SHC rises 1.8% to $18.55
- Closed at $18.55, +1.81% vs the prior close of $18.22. Day range $18.16–$18.71, opened at $18.28.
- Volume was 2.51M shares, 1.0x its 50-day average of 2.43M.
- Price is -0.5% vs its 50-day average ($18.65) and +9.1% vs its 200-day average ($17.00).
- 52-week range $13.09–$19.85; today's close sits at 81% of that range, 6.5% below the 52-week high.
Oct 2, 2026 — SHC rises 0.6% to $18.22
- Closed at $18.22, +0.55% vs the prior close of $18.12. Day range $17.99–$18.47, opened at $17.99.
- Volume was 2.08M shares, 0.8x its 50-day average of 2.50M.
- Price is -2.2% vs its 50-day average ($18.63) and +7.3% vs its 200-day average ($16.99).
- 52-week range $13.09–$19.85; today's close sits at 76% of that range, 8.2% below the 52-week high.
SHC latest news & SEC filings
Every SEC filing by or about SHC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 9, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 19, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Petras Michael B. Jr. sold 294,515 shares at $18.50 (≈$5.45M) on Aug 17, 2026
- Petras Michael B. Jr. sold 850,000 shares at $18.50 (≈$15.72M) on Aug 17, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 17, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 14, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 11, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Rutz Michael P sold 150,000 shares at $18.84 (≈$2.83M) on Aug 7, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 7, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 7, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 6, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $321.38M (prior year $294.34M) (+9.2% vs Jun 30, 2025)
- Net income: $53.64M (prior year $7.96M) (+573.7% vs Jun 30, 2025)
- Diluted EPS: $0.19 (prior year $0.03) (+533.3% vs Jun 30, 2025)
Aug 6, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 30, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade SHC
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 5, 2026, Feb 24, 2026, Jan 12, 2026. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.10% (largest 2.6%).
- Liquidity: about 2.03M shares (≈$36.75M) trade per day on average.
- 52-week position: $18.07 vs a range of $13.09–$19.85 (74% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Michael B. Jr. Petras sold 294,515 shares on Aug 17, 2026.
- Latest filings: 8-K Aug 14, 2026; 10-Q Aug 6, 2026; 8-K Aug 6, 2026.
- Share count: 285.37M shares outstanding (Jul 30, 2026), +0.5% vs a year earlier.
- Listing: Nasdaq · industry: Services-Misc Health & Allied Services, NEC.
SHC market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 17.88 | 18.19 | 17.71 | 18.07 | 2.43M |
| Oct 14, 2026 | 17.82 | 18.02 | 17.62 | 17.73 | 2.28M |
| Oct 13, 2026 | 18.19 | 18.32 | 17.92 | 18.21 | 1.65M |
| Oct 12, 2026 | 18.04 | 18.16 | 17.94 | 18.15 | 1.56M |
| Oct 9, 2026 | 17.83 | 18.24 | 17.65 | 18.06 | 1.60M |
| Oct 8, 2026 | 17.80 | 18.25 | 17.51 | 17.83 | 2.25M |
| Oct 7, 2026 | 18.13 | 18.69 | 17.87 | 17.90 | 1.61M |
| Oct 6, 2026 | 18.77 | 18.98 | 18.19 | 18.25 | 1.65M |
| Oct 5, 2026 | 18.28 | 18.71 | 18.16 | 18.55 | 2.51M |
| Oct 2, 2026 | 17.99 | 18.47 | 17.99 | 18.22 | 2.08M |
| Oct 1, 2026 | 18.40 | 18.49 | 18.09 | 18.12 | 1.64M |
| Sep 30, 2026 | 18.68 | 18.76 | 18.39 | 18.49 | 2.03M |
| Sep 29, 2026 | 18.43 | 18.65 | 18.27 | 18.60 | 1.64M |
| Sep 28, 2026 | 18.28 | 18.55 | 18.21 | 18.45 | 1.39M |
| Sep 25, 2026 | 18.44 | 18.58 | 18.21 | 18.34 | 1.25M |
| Sep 24, 2026 | 18.24 | 18.63 | 18.23 | 18.45 | 1.32M |
| Sep 23, 2026 | 18.68 | 18.82 | 18.17 | 18.29 | 1.76M |
| Sep 22, 2026 | 18.79 | 18.95 | 18.62 | 18.69 | 1.50M |
| Sep 21, 2026 | 18.81 | 18.94 | 18.52 | 18.70 | 2.15M |
| Sep 18, 2026 | 18.94 | 19.01 | 18.66 | 18.73 | 6.38M |
About Sotera Health
Sotera Health (SHC) is listed on the Nasdaq and classified by the SEC under “Services-Misc Health & Allied Services, NEC”. Its business address is in BROADVIEW HEIGHTS, OH. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1822479.
SHC board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Co-Invest L.P. Bull | Director | May 15, 2026 |
| Holdco L.P. Bull | Director | May 15, 2026 |
| Sean Laurence Cunningham | Director | May 27, 2026 |
| Ruoxi Chen | Director | May 27, 2026 |
| Karen Flynn | Director | May 27, 2026 |
| Co-Invest Xi Lp Gtcr | Director | May 15, 2026 |
| Fund Xi/A Lp Gtcr | Director | May 15, 2026 |
| Fund Xi/C Lp Gtcr | Director | May 15, 2026 |
| Investment Xi Llc Gtcr | Director | May 15, 2026 |
| Partners Xi/A&C Lp Gtcr | Director | May 15, 2026 |
| Ann R. Klee | Director | May 27, 2026 |
| Kenneth D. Krause | Director | May 27, 2026 |
| Richard G Kyle | Director | May 27, 2026 |
| James Neary | Director | May 27, 2026 |
| Vincent K Petrella | Director | May 27, 2026 |
| Michael B. Jr. Petras | Executive Chairman | Aug 19, 2026 |
| Alton Shader | Chief Executive Officer | May 27, 2026 |
| Christopher Simon, | Director | May 27, 2026 |
| Pincus & Co. Warburg | Director | May 15, 2026 |
| Pincus Llc Warburg | Director | May 15, 2026 |
| Global Llc Wp | Director | May 15, 2026 |
| Xi Partners, L.P. Wp | Director | May 15, 2026 |
| Pincus (Bermuda) Private Equity Gp Ltd. Warburg | Director | May 15, 2026 |
| Pincus (Cayman) Xi, L.P. Warburg | Director | May 15, 2026 |
| Pincus Partners Gp Llc Warburg | Director | May 15, 2026 |
| Pincus Partners Ii (Cayman), L.P. Warburg | Director | May 15, 2026 |
| Pincus Partners Ii, L.P. Warburg | Director | May 15, 2026 |
| Pincus Private Equity Xi, L.P. Warburg | Director | May 15, 2026 |
| Pincus Private Equity Xi-B, L.P. Warburg | Director | May 15, 2026 |
| Pincus Private Equity Xi-C, L.P. Warburg | Director | May 15, 2026 |
| Pincus Xi Partners, L.P. Warburg | Director | May 15, 2026 |
| Pincus Xi, L.P. Warburg | Director | May 15, 2026 |
| Pincus Xi-C, Llc Warburg | Director | May 15, 2026 |
| David E. Wheadon | Director | May 27, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Alexander Dimitrief | Former SVP, GC and Sec. | Apr 2, 2026 |
| Jonathan M. Lyons | Sr. Vice President, CFO | Aug 7, 2026 |
| Erika Ostrowski | SVP, General Counsel and Sec. | Apr 8, 2026 |
| Michael B. Jr. Petras | Executive Chairman | Aug 19, 2026 |
| Michael P Rutz | President of Sterigenics | Aug 11, 2026 |
| Alton Shader | Chief Executive Officer | May 27, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 17, 2026 | Michael B. Jr. Petras | Sale | 294,515 | $18.50 |
| Aug 17, 2026 | Michael B. Jr. Petras | Sale | 850,000 | $18.50 |
| Aug 7, 2026 | Michael P Rutz | Sale | 150,000 | $18.84 |
| May 13, 2026 | Pincus (Cayman) Xi, L.P. Warburg | Sale | 19,102,952 | $15.17 |
| May 13, 2026 | Pincus & Co. Warburg | Sale | 19,102,952 | $15.17 |
| May 13, 2026 | Pincus Llc Warburg | Sale | 19,102,952 | $15.17 |
| May 13, 2026 | Pincus (Bermuda) Private Equity Gp Ltd. Warburg | Sale | 19,102,952 | $15.17 |
| May 13, 2026 | Pincus Private Equity Xi-C, L.P. Warburg | Sale | 19,102,952 | $15.17 |
| May 13, 2026 | Pincus Partners Gp Llc Warburg | Sale | 19,102,952 | $15.17 |
| May 13, 2026 | Pincus Partners Ii (Cayman), L.P. Warburg | Sale | 19,102,952 | $15.17 |
| May 13, 2026 | Pincus Xi-C, Llc Warburg | Sale | 19,102,952 | $15.17 |
| May 13, 2026 | Fund Xi/C Lp Gtcr | Sale | 12,735,301 | $15.17 |
| May 13, 2026 | Co-Invest Xi Lp Gtcr | Sale | 12,735,301 | $15.17 |
| May 13, 2026 | Fund Xi/A Lp Gtcr | Sale | 12,735,301 | $15.17 |
| May 13, 2026 | Investment Xi Llc Gtcr | Sale | 12,735,301 | $15.17 |
SHC financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $1.16B | $77.95M | 0.27 | $287.19M |
| Dec 31, 2024 | $1.10B | $44.40M | 0.16 | $224.16M |
| Dec 31, 2023 | $1.05B | $51.38M | 0.18 | $-147.73M |
| Dec 31, 2022 | $1.00B | $-233.57M | -0.83 | $277.96M |
| Dec 31, 2021 | $931.48M | $116.88M | 0.41 | $281.55M |
Latest balance sheet: total assets $3.31B, total liabilities $2.64B, cash $356.72M (as of Jun 30, 2026).
SHC earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $18.91 |
| May 5, 2026 | 8-K Item 2.02 (results) | $15.33 |
| Feb 24, 2026 | 8-K Item 2.02 (results) | $16.72 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $18.99 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $16.43 |
| Aug 8, 2025 | 8-K Item 2.02 (results) | $13.97 |
| May 1, 2025 | 8-K Item 2.02 (results) | $12.10 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $12.28 |
| Jan 14, 2025 | 8-K Item 2.02 (results) | $12.76 |
| Nov 5, 2024 | 8-K Item 2.02 (results) | $15.42 |
| Aug 5, 2024 | 8-K Item 2.02 (results) | — |
| May 2, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Misc Health & Allied Services, NEC
Davita (DVA)Fresenius Medical Care AG (FMS)Progyny (PGNY)agilon health (AGL)Viemed Healthcare (VMD)NewGenIvf (NIVF)Park Dental Partners (PARK)Mangoceuticals (MGRX)Cryo Cell International (CCEL)BioRestorative Therapies (BRTX)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on SHC
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.